Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Gene Therapy Reports

Jan 03, 2023

Gilead Buys Out Rights to Cancer Therapy from Jounce; FDA Places Clinical Hold on Biogen’s Orelabrutinib; Pfizer Announces Phase 3 BENEGENE-2 Study Result; FDA Approves MediWound’s NexoBrid; UCB Announces FDA Acceptance of BLA Resubmission for Bimekizumab; FDA Approves TG Therapeutics’ Briumvi

Nov 18, 2022

Gene Therapy: The Next Milestone in Treating Complex Diseases

Apr 19, 2019

Can commoners afford to spend million dollars on GENE Therapy?

Jan 19, 2015

Suicide Gene Therapy: Where do we stand?

Jan 06, 2015

Are you ready to embrace Gene Therapy?

Dec 30, 2014

DelveInsight’s Respiratory disorders based Gene Therapy Reports

Newsletter/Whitepaper